Bristol Myers Squibb Co is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Oct. 26, 2026 and Nov. 2, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.
How the next-report window is calculated
Bristol Myers Squibb Co's most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed July 30, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.
SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Bristol Myers Squibb Co filed between 24 and 31 days after period end (median 30 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.
Recent filings by Bristol Myers Squibb Co
| Filed | Form | What it is | Document |
|---|---|---|---|
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-08-07 · Index 0000093751-26-000422 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended June 30, 2026 | Open 10-Q filed 2026-07-30 · Index 0000014272-26-000020 | |
| 8-K | Released earnings or financial results; information shared under Regulation FD | Open 8-K filed 2026-07-30 · Index 0000014272-26-000018 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-05 · Index 0000014272-26-000016 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-05 · Index 0000014272-26-000015 | |
| 11-K | Annual report of an employee stock purchase or savings plan | Open 11-K filed 2026-06-05 · Index 0000014272-26-000014 | |
| S-8 | Registration of shares for employee benefit plans | Open S-8 filed 2026-05-08 · Index 0001140361-26-020060 | |
| 8-K | Reported shareholder vote results | Open 8-K filed 2026-05-08 · Index 0001140361-26-020036 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended March 31, 2026 | Open 10-Q filed 2026-04-30 · Index 0000014272-26-000010 | |
| 8-K | Released earnings or financial results; information shared under Regulation FD | Open 8-K filed 2026-04-30 · Index 0000014272-26-000008 | |
| 13G | Ownership above 5% by a passive or institutional investor | Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000248 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-04-17 · Index 0001140361-26-015377 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000896 | |
| ARS | Annual report delivered to shareholders | Open ARS filed 2026-03-25 · Index 0001140361-26-011149 | |
| DEFA14A | Additional proxy soliciting materials | Open DEFA14A filed 2026-03-25 · Index 0001140361-26-011110 | |
| DEF 14A | Definitive proxy statement for a shareholder meeting | Open DEF 14A filed 2026-03-25 · Index 0000014272-26-000006 | |
| 10-K | Annual report with audited financial statements for the period ended Dec. 31, 2025 | Open 10-K filed 2026-02-11 · Index 0000014272-26-000004 | |
| 8-K | Released earnings or financial results; information shared under Regulation FD | Open 8-K filed 2026-02-05 · Index 0000014272-26-000002 | |
| 8-K | Information shared under Regulation FD | Open 8-K filed 2026-01-12 · Index 0001140361-26-000929 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2025-11-18 · Index 0001140361-25-042607 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2025-11-10 · Index 0001140361-25-041380 | |
| 8-K | Other events the company chose to report | Open 8-K filed 2025-11-03 · Index 0001140361-25-040066 | |
| 13G/A | Amendment to a passive-ownership (13G) report | Open SCHEDULE 13G/A filed 2025-10-31 · Index 0000019617-25-001051 | |
| 10-Q | Quarterly report with unaudited financial statements for the period ended Sept. 30, 2025 | Open 10-Q filed 2025-10-30 · Index 0000014272-25-000149 | |
| 8-K | Released earnings or financial results; information shared under Regulation FD | Open 8-K filed 2025-10-30 · Index 0000014272-25-000147 |
What Bristol Myers Squibb Co's 8-Ks were about in the past year
Bristol Myers Squibb Co filed 9 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.
| Item | Meaning | Times |
|---|---|---|
| 9.01 | Financial Statements and Exhibits | 8 |
| 7.01 | Regulation FD Disclosure | 5 |
| 2.02 | Results of Operations and Financial Condition | 4 |
| 8.01 | Other Events | 3 |
| 5.07 | Submission of Matters to a Vote of Security Holders | 1 |